TITLE

Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status

AUTHOR(S)
Spruit, M. A.; Thomeer, M. J.; Gosselink, R.; Troosters, T.; Kasron, A.; Debrock, A. J. T.; Dernedts, M. G.; Decramer, M.
PUB. DATE
January 2005
SOURCE
Thorax;Jan2005, Vol. 60 Issue 1, p32
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Skeletal muscle weakness is assumed to be present in patients with sarcoidosis but has never been reported in a consecutive group of patients. Moreover, its relationship with: previously observed exercise intolerance and reduced health status has never been. studied in these patients. Methods: Pulmonary function, skeletal and respiratory muscle forces, peak and functional exercise capacity, health status, and the circulating levels of inflammatory and anabolic markers were determined in 25 patients with sarcoidosis who complained of fatigue (15 men) and in 21 healthy subjects (13 men). Results: Patients with sarcoidosis had lower respiratory and skeletal muscle forces, reduced exercise capacity and health status, higher anxiety and depression scores, and higher circulating levels of tumour necrosis factor-α than healthy subjects (all p ⩽ 0.01). Its soluble receptor p75 tended to be higher (p = 0.04). Circulating levels of interleukin (IL)-6, IL-8, insulin-like growth factor I and its binding, protein 3 were not significantly different between the two groups. Skeletal muscle weakness was related to exercise intolerance, depression, and reduced health status in patients with sarcoidosis, irrespective of age, sex, body weight and height (p ⩽ 0.05). Quadriceps peak torque was inversely related to fatigue but not to the circulating levels of inflammatory or anabolic markers. The mean daily dose of corticosteroids received in the 6 month period before testing was related to quadriceps peak torque only in patients who received oral corticosteroids. Conclusion: Skeletal muscle weakness occurs in patients with sarcoidosis who complain of fatigue and is associated with reduced health status and exercise intolerance.
ACCESSION #
16163703

 

Related Articles

  • Variation in the Lymphotoxin-α/Tumor Necrosis Factor Locus Modifies Risk of Erythema Nodosum in Sarcoidosis. McDougal, Kathryn E.; Fallin, M Daniele; Moller, David R.; Zhimin Song; Cutler, David J.; Steiner, Lori L.; Cutting, Garry R. // Journal of Investigative Dermatology;Aug2009, Vol. 129 Issue 8, p1921 

    Sarcoidosis is a multi-system inflammatory disease with organ involvement that varies by race and sex. Family studies indicate that genes play a role in the etiology and extent of organ involvement in sarcoidosis. In this study, we evaluated whether 25 variants distributed in 19 genes with a...

  • A Problematic Palsy: An Exercise in Clinical Reasoning. Einstein, David; Trowbridge, Robert; Rencic, Joseph // JGIM: Journal of General Internal Medicine;Jul2015, Vol. 30 Issue 7, p1029 

    The article presents a case study of a 29-year-old African American woman whop presented to her primary care physician with a complain of one week of fatigue, malaise, and generalized mild abdominal discomfort. She had anorexia and had developed a left-sided facial droop two weeks later upon...

  • Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients. Tzouvelekis, Argyris; Ntolios, Paschalis; Karameris, Andreas; Koutsopoulos, Anastasios; Boglou, Panagiotis; Koulelidis, Andreas; Archontogeorgis, Kostas; Zacharis, George; Drakopanagiotakis, Fotis; Steiropoulos, Paschalis; Anevlavis, Stavros; Polychronopoulos, Vlassis; Mikroulis, Dimitrios; Bouros, Demosthenes // BMC Research Notes;2012, Vol. 5 Issue 1, p654 

    Background: Sarcoidosis is a granulomatous disorder of unknown etiology. The term of immunoangiostasis has been addressed by various studies as potentially involved in the disease pathogenesis. The aim of the study was to investigate the expression of the master regulator of angiogenesis hypoxia...

  • Differential response to corticosteroid therapy of MRI findings and clinical manifestations in spinal cord sarcoidosis. Koike, Haruki; Misu, Ken-ichiro; Yasui, Keizo; Kameyama, Takashi; Ando, Tetsuo; Yanagi, Tsutomu; Sobue, Gen // Journal of Neurology;Jul2000, Vol. 247 Issue 7, p544 

    Spinal cord sarcoidosis is a rare disorder whose natural history and therapeutic outcome are not fully known. We examined four patients with spinal cord sarcoidosis both clinically and radiologically, particularly in relation to corticosteroid treatment. The initial manifestation was cervical...

  • Two cases of hypothalamic-pituitary sarcoidosis. Smith, D.; Cullen, M. J. // Journal of the Royal Society of Medicine;Apr2005, Vol. 98 Issue 4, p167 

    The article cites two cases diagnosed of sarcoidosis of a 34 years old man in 1981 and 59 years old farmer in 1988. It is reported that sarcoidosis was a multisystem granulomatous disorder affecting the hypothalamus and pituitary glands. First patient experienced nausea, weight loss, depression,...

  • A Guide to Treatment of Sarcoidosis. Papanikolaou, Ilias C.; Shigemitsu, Hidenobu; Sharma, Om P. // Current Drug Therapy;May2010, Vol. 5 Issue 2, p122 

    Not all sarcoidosis patients need treatment. In about 40% of cases, disease will subside spontaneously. For the rest who need to be treated, older drugs like corticosteroids, methotrexate and hydroxychloroquine, as well as the more recent anti-TNF agents, will be effective in suppressing...

  • Health Hot Line SARCOIDOSIS.  // Ebony;Mar2004, Vol. 59 Issue 5, p144 

    Provides information on sarcoidosis among Afro-American women. Prevalence of the disease in the U.S.; Symptoms of sarcoidosis; Use of corticosteroids for the treatment of the disease.

  • Sarcoid tubulo-interstitial nephritis: Long-term outcome and response to corticosteroid therapy. Rajakariar, R.; Sharples, E. J.; Raftery, M. J.; Sheaff, M.; Yaqoob, M. M. // Kidney International;Jul2006, Vol. 70 Issue 1, p165 

    Sarcoidosis is a chronic relapsing multi-systemic disorder characterized by the development of non-caseating granulomas. Granulomatous tubulo-interstitial nephritis is an uncommon manifestation of this condition. We identified 39 patients with sarcoidosis and renal disease from a single center...

  • Practical Issues and Challenges in the Diagnosis and Treatment of Pulmonary Sarcoidosis. Jindal, Surinder K. // Drugs;2007, Vol. 67 Issue 1, p17 

    Sarcoidosis is a granulomatous disease with multisystem involvement. Diagnosis is generally easy to establish from the characteristic clinical and radiographic features. In India and other developing countries, tuberculosis is the closest clinical mimic and needs to be excluded before therapy...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics